1. Bayesian methods for evidence synthesis in cost-effectiveness analysis

   • A. E. Ades
   • Mark Sculpher
   • Guobing Lu

   Leading Article 17 September 2012 Pages: 1 - 19

   

2. Costs of irritable bowel syndrome in the UK and US

   • Stefanie Maxion-Bergemann
   • Frank Thielecke
   • Rito Bergemann

   Review Article 17 September 2012 Pages: 21 - 37

   

3. Too important to ignore

   • Werner B. F. Brouwer

   Commentary 17 September 2012 Pages: 39 - 41

4. Incorporating carer effects into economic evaluation

   • Simon Dixon
   • Mel Walker
   • Sam Salek

   Original Research Article 17 September 2012 Pages: 43 - 53

   

5. Interstitial cystitis

   • Eric Q. Wu
   • Howard Birnbaum
   • Haya Taitel

   Original Research Article 17 September 2012 Pages: 55 - 65

   

6. Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK

   • Phil McEwan
   • Simon Dixon
   • Craig J. Currie

   Original Research Article 17 September 2012 Pages: 67 - 79

   

7. Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis

   • Antonio Gómez-Outes
   • Eduardo Rocha
   • Vijay V. Kakkar

   Original Research Article 17 September 2012 Pages: 81 - 92

   

8. Economic evaluation of rivastigmine in patients with Parkinson’s disease dementia

   • Andrew R. Willan
   • Ron Goeree
   • Gordon Blackhouse

   Original Research Article 17 September 2012 Pages: 93 - 106